VIA Versus Colposcopy
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age25-65
SponsorSohag University
About this trial
The aim of this study is to compare the effectiveness of visual inspection with acetic acid (VIA) versus colposcopy in terms of sensitivity and specificity in diagnosis of pre-malignant cervical lesions among women, and to assess the awareness of women regarding cervical cancer screening methods.
Eligibility criteria
Qualifiers
Age from 25 to 65 years.
Patient undergoing cervical cancer screening using VIA and colposcopy.
Women with symptoms such as white discharge, post-coital bleeding, and intermenstrual bleeding.
Women with the clinically unhealthy cervix (erosion, bleeding on touch, simple leukoplakia, keratinization)
Disqualifiers
• Pregnant women (if VIA or colposcopy is contraindicated).
Women with obvious invasive cervical cancer diagnosed previously.
Women who refuse to provide informed consent or are unable to cooperate with the examination.
Women having active vaginal bleeding.
Trial design
Treatments tested in this trial
- VIA
Treatment groups
No treatment groups listed
Locations
Sponsors and collaborators
Source ClinicalTrials.gov